Kyung Hee University at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Kyung Hee University brings 9 presentations to ESGCT 2026 in Hamburg. Its work centres on RNA therapeutics, including bispecific siRNA against blood lipid targets and platforms that read through nonsense mutations or reprogram splicing. A second strand uses AAV delivery to the retina and the nervous system.
| Organization | ESGCT 2026 Attendance |
|---|---|
Kyung Hee University Seoul, South Korea | |
Poster Wed Oct 28 1:30pm–3:30pm AAV2-mediated retinal delivery of DX2 preserves photoreceptor structure and retinal function in a mouse model of retinal degeneration Vectors and delivery (AAV, lentiviral, LNP)Rare and inherited disease Poster Wed Oct 28 1:30pm–3:30pm Development of a GalNAc-conjugated bispecific siRNA enabling simultaneous silencing of APOC3 and PCSK9 for dyslipidemia treatment Poster Wed Oct 28 1:30pm–3:30pm NOX4-mediated oxidative stress promotes prostatic remodeling in benign prostatic hyperplasia Poster Wed Oct 28 1:30pm–3:30pm Rational Design of a Dual-Guide Bi-Specific DsiRNA Therapeutic Candidate for Simultaneous Suppression of HBV Transcripts and PD-L1/CD274 RNA and oligonucleotide therapies Poster Wed Oct 28 1:30pm–3:30pm TRAP-Sec: A trans-acting RNA platform for targeted nonsense mutation read-through via programmable selenocysteine insertion Poster Thu Oct 29 2:00pm–4:00pm AAV2-Mediated DX2 Delivery as an Agnostic Therapeutic Strategy for ALS and Neurodegenerative Diseases Poster Thu Oct 29 2:00pm–4:00pm ASO-Guided N-of-1 Trial Platform for CDG Poster Thu Oct 29 2:00pm–4:00pm DX2-mediated preservation of TRAF2 suppresses downstream inflammatory and pro-apoptotic stress signaling. Poster Thu Oct 29 2:00pm–4:00pm Programmable Intron-to-Exon Conversion via Engineered U1 and U2 snRNAs |
Instantly find 20 buyers from Kyung Hee University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction